A novel mutation in AGL gene causes Glycogen storage disease type III
Publish place: the fourth International and 16th National Genetics Congress
Publish Year: 1399
نوع سند: مقاله کنفرانسی
زبان: English
View: 280
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
CIGS16_287
تاریخ نمایه سازی: 14 اردیبهشت 1400
Abstract:
Background and Aim: Glycogen storage disease type III (GSDIII) is a rare autosomal recessive disorder caused by deficiency of the glycogen debranching enzyme. (amylo-۱,۶-glucosidase, ۴-alpha-glucanotransferase (AGL)) activity. GSD III, also known as Forbes or Cori's disease, is characterized by the accumulation of abnormal glycogen in the liver and muscles.Methods: We collected ۵-mL of peripheral blood from a patient presenting GSD symptoms. DNA was isolated using salting out method. The coding region and intron–exon boundaries of the AGL were amplified using PCR. PCR purification and bidirectional Sanger sequencing of the PCR products were done.Results: We identified a novel substitution; c.۳۶۸۲C>T, p.Arg۱۲۲۸X. According to the insilico analysis we suggest the variation is probably damaging.Conclusion: A novel mutation in the AGL gene, c.۳۶۸۲C>T in an Iranian affected person was identified. This mutation affects the C-terminal region of the protein. Mutation of this region disrupts glucosidase activity of the enzyme. It should be considered in genetic assessment of the patients suffering GSD in Southwest of Iran.
Keywords:
Authors
Atefe papi
Department of Genetics, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
hamid galehdari
Jondishapour University of Medical Sciences, Ahvaz, Iran. Narges Medical Genetics Laboratory
Gholamreza Shariati
Jondishapour University of Medical Sciences, Ahvaz, Iran. Narges Medical Genetics Laboratory
Mina Zamani
Narges Medical Genetics Laboratory
Jawaher Zeighami
Narges Medical Genetics Laboratory
Tahereh Yadegari
Narges Medical Genetics Laboratory